Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Results 1 - 14 of 14

Recs

2
Member Avatar jschinagle (< 20) Submitted: 5/13/2013 4:26:19 PM : Underperform Start Price: $1.17 ENZN Score: +33.76

nothing left after large liquidating dividend

Recs

0
Member Avatar Hotpicks101 (28.93) Submitted: 1/21/2011 6:11:35 PM : Outperform Start Price: $3.14 ENZN Score: -126.83

Klarman. Cheap.

Recs

0
Member Avatar jsgant13 (99.10) Submitted: 9/13/2010 1:01:00 PM : Outperform Start Price: $2.97 ENZN Score: -147.82

baupost, deej and value

Recs

0
Member Avatar NoIcons (< 20) Submitted: 2/28/2010 6:33:42 PM : Outperform Start Price: $2.55 ENZN Score: -143.59

outperform

Recs

0
Member Avatar healthcare1 (< 20) Submitted: 1/17/2009 5:04:27 AM : Outperform Start Price: $1.69 ENZN Score: -185.92

it has a unique drug delivery system and activist shareholders

Recs

0
Member Avatar mjan706 (68.78) Submitted: 9/22/2008 1:44:10 AM : Outperform Start Price: $2.14 ENZN Score: -119.75

An Icahn portfolio stock.

Recs

0
Member Avatar hennessy7 (52.29) Submitted: 5/26/2008 9:12:50 AM : Outperform Start Price: $2.40 ENZN Score: -110.57

I like the sector. This is a sector pick as I have done little DD on this stock. I think small biotech has been hit hard, and the cancer market, in particular, is going to turn around. Plus, I do not see too many incredible investments in other sectors so I am sticking to high risk/ high reward opportunities.

Recs

0
Member Avatar WonderWolf (55.97) Submitted: 5/20/2008 11:48:35 PM : Outperform Start Price: $2.41 ENZN Score: -106.32

Working on 2 cancer drugs and will be the big winner!!

Recs

0
Member Avatar Addgirl48 (62.05) Submitted: 3/29/2008 11:21:19 AM : Outperform Start Price: $2.52 ENZN Score: -120.41

People all ways needing pills so Pharmaceuticals all ways geting business and all ways will

Recs

0
Member Avatar djinsanity (< 20) Submitted: 2/9/2008 12:17:36 PM : Outperform Start Price: $2.21 ENZN Score: -112.92

PEG-SN38 showed anti-tumor activity in resistant pre-clinical models, FDA approval for DepoCyt, leader in stem cell research, I can see it doing phenomenal

Recs

0
Member Avatar henncoop (87.56) Submitted: 3/7/2007 11:04:59 AM : Outperform Start Price: $2.24 ENZN Score: -108.85

low PE &amp; a good choice for a play in this sector

Recs

0
Member Avatar pbqstraining (< 20) Submitted: 1/12/2007 10:52:34 PM : Outperform Start Price: $2.32 ENZN Score: -106.83

NICE PIPELINE

Recs

0
Member Avatar j3nzsrfs (< 20) Submitted: 11/25/2006 10:29:17 PM : Outperform Start Price: $2.27 ENZN Score: -108.79

New cancer treatment

Recs

0
Member Avatar MadisonClub1 (< 20) Submitted: 11/22/2006 8:11:36 PM : Outperform Start Price: $2.27 ENZN Score: -108.75

All looks bad for it but ....just a feeling

Results 1 - 14 of 14

Featured Broker Partners


Advertisement